Topic: Optical
BusinesWeek reports that Bausch & Lomb has finally acquired the drug Miochol-E from Novartis AG. Novartis had to stop selling Miochol-E if it were to buy Alcon, according to a Federal Trade Commission ruling. Why? Novartis and Alcon are the only two companies that sell injectable miotics, drugs that stabilize the iris during cataract surgery. Now Novartis will finalize its purchase of Alcon.
